Kenvue Inc. logo

Kenvue Inc. (J4D)

Market Closed
10 Aug, 16:50
XFRA XFRA
16. 48
-0
-0.0303%
- Market Cap
21.62 P/E Ratio
0.83% Div Yield
1,205 Volume
1.14 Eps
16.49
Previous Close
Add Transaction
Day Range
16.3 16.48
Year Range
11.83 18.23
Want to track J4D and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

J4D closed today lower at €16.48, a decrease of -0.0303% from yesterday's close, completing a monthly increase of 0.7025% or €0.11. Over the past 12 months, J4D stock gained 14.5269%.
J4D pays dividends to its shareholders, with the most recent payment made on May 27, 2026. The next announced payment will be in In 2 weeks on Aug 26, 2026 for a total of €0.21.
The last earnings report, released on May 07, 2026, missed the consensus estimates by -0.26%. On average, the company has fell short of earnings expectations by -0.24%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

J4D Chart

KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise

KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise

Kenvue posts higher Q2 sales and earnings, but both miss estimates as inflation, tariffs and foreign exchange pressure margins.

Zacks | 4 days ago
Kenvue second quarter results fall short of expectations, sending shares lower

Kenvue second quarter results fall short of expectations, sending shares lower

Kenvue Inc (NYSE:KVUE) shares fell about 2% on Thursday after the consumer health company reported second quarter results that narrowly missed Wall Street expectations, while margins declined from a year earlier. The company reported adjusted diluted earnings per share of $0.31, compared with the $0.32 consensus estimate.

Proactiveinvestors | 4 days ago
Kenvue (KVUE) Lags Q2 Earnings and Revenue Estimates

Kenvue (KVUE) Lags Q2 Earnings and Revenue Estimates

Kenvue (KVUE) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.29 per share a year ago.

Zacks | 4 days ago

Kenvue Inc. (J4D) FAQ

What is the stock price today?

The current price is €16.48.

On which exchange is it traded?

Kenvue Inc. is listed on XFRA.

What is its stock symbol?

The ticker symbol is J4D.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.83%.

What is its market cap?

As of today, no market cap data is available.

Has Kenvue Inc. ever had a stock split?

No, there has never been a stock split.

Kenvue Inc. Profile

Household Products Industry
Consumer Staples Sector
Kirk L. Perry CEO
XFRA Exchange
49177J102 CUSIP
US Country
22,000 Employees
12 Aug 2026 Last Dividend
- Last Split
4 May 2023 IPO Date

Overview

Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.

Products and Services

  • Self Care: This segment encompasses products for cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and more. Notable brands include Tylenol for pain relief, Motrin for inflammation, Benadryl for allergies, Nicorette for smoking cessation, Zarbee's and ORSLTM for general wellness, Rhinocort for nasal congestion, Calpol for children's fever and pain, and Zyrtec for 24-hour allergy relief.
  • Skin Health and Beauty: Dedicated to maintaining skin health and enhancing beauty, this segment offers products for face and body care, hair care, sun protection, and more. It includes Neutrogena for skincare and acne treatment, Aveeno for moisturizers with natural ingredients, Dr.Ci:Labo for innovative skin solutions, Le Petit Marseillais for shower gels and soaps with enchanting fragrances, Lubriderm for daily moisture, Rogaine for hair regrowth, and OGX for salon-inspired hair care.
  • Essential Health: Focusing on essential healthcare needs, this segment provides oral care, baby care, women's health, wound care, among other products. It features Listerine for oral health, Johnson's products for baby care, Band-Aid for wound protection, Stayfree pads, o.b. tampons, and Carefree liners for feminine hygiene, as well as Desitin Diaper Rash cream to soothe and protect infants.

Contact Information

Address: 1 Kenvue Way
Phone: 908 874 1200